Prognostic Value of Serial Measurement of Serum Des-Arg(6)-Bradykinin Levels in Severe COVID-19 Patients.

Pinar Aysert-Yildiz, H Selcuk Ozger, Yesim Yildiz, Merve Buyukkoruk, Mehmet Yildiz, T Saadet Deveci-Bulut, Ozlem Gulbahar, Murat Dizbay

Clinical laboratory 2022 Jul 01

filter terms:

Excessive inflammatory immune response during SARS-CoV-2 infection contributes to severe disease in COVID-19 patients. Recently, some researchers hypothesized that dysregulation of the bradykinin (BK) system may also play a role in the pathogenesis of severe disease. Des-Arg(9)-bradykinin (DABK), an active metabolite of BK, is responsible for vasodilatation and increased permeability in the lungs and regulated by angiotensin converting enzyme 2 (ACE-2). Viral inhibition of ACE-2 by SARS-CoV-2 increases DABK levels. Serum levels of this metabolite may be linked to disease severity in COVID-19 patients. In this study, it is aimed to investigate the prognostic value of serial measurement of serum DABK levels in severe COVID-19 patients. This prospective cohort study was conducted in hospitalized severe COVID-19 patients. Serum DABK levels of patients were serially measured on day 0, day 3 and day 5. Patients were categorized as cases with poor or good prognosis and critical or non-critical cases. Serum DABK levels of these patient groups were compared with paired sample t-test. Serum DABK levels on different days in the same patients were compared with repeated measures ANOVA tests. There was no statistically significant difference in serum DABK levels measured at day 0, day 3, and day 5 between good and poor prognosis groups. DABK levels in critical and non-critical COVID-19 patients also did not show any significant difference. According to our results serially measured serum DABK levels did not correlate with outcome of severe COVID-19 and do not have prognostic value in severe COVID-19 patients.

Citation

Pinar Aysert-Yildiz, H Selcuk Ozger, Yesim Yildiz, Merve Buyukkoruk, Mehmet Yildiz, T Saadet Deveci-Bulut, Ozlem Gulbahar, Murat Dizbay. Prognostic Value of Serial Measurement of Serum Des-Arg(6)-Bradykinin Levels in Severe COVID-19 Patients. Clinical laboratory. 2022 Jul 01;68(7)